G. K. Scadding

2.4k total citations
24 papers, 1.3k citations indexed

About

G. K. Scadding is a scholar working on Immunology and Allergy, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. K. Scadding has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology and Allergy, 17 papers in Physiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. K. Scadding's work include Allergic Rhinitis and Sensitization (19 papers), Asthma and respiratory diseases (17 papers) and Respiratory and Cough-Related Research (4 papers). G. K. Scadding is often cited by papers focused on Allergic Rhinitis and Sensitization (19 papers), Asthma and respiratory diseases (17 papers) and Respiratory and Cough-Related Research (4 papers). G. K. Scadding collaborates with scholars based in United Kingdom, France and Germany. G. K. Scadding's co-authors include Joaquim Mullol, Jean Bousquet, Giorgio Walter Canonica, JC Virchow, Sameh M. Ragab, Y. Darby, V J Lund, Hesham Saleh, Abhi Parikh and Valerie J. Lund and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and British Journal of Pharmacology.

In The Last Decade

G. K. Scadding

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. K. Scadding United Kingdom 16 1.0k 889 344 264 208 24 1.3k
R. M. SUDDERICK United Kingdom 9 939 0.9× 1.0k 1.2× 138 0.4× 245 0.9× 21 0.1× 14 1.3k
B.Lauren Charous United States 11 246 0.2× 212 0.2× 166 0.5× 149 0.6× 21 0.1× 18 649
Eliot H. Dunsky United States 17 370 0.4× 399 0.4× 84 0.2× 199 0.8× 20 0.1× 26 832
Aarif O. Eifan United Kingdom 17 982 1.0× 967 1.1× 26 0.1× 173 0.7× 55 0.3× 31 1.3k
Kristina Irander Sweden 13 286 0.3× 274 0.3× 41 0.1× 128 0.5× 27 0.1× 24 503
Hossein Esmaeilzadeh Iran 13 161 0.2× 228 0.3× 87 0.3× 119 0.5× 21 0.1× 57 553
Maria Xatzipsalti Greece 9 255 0.3× 362 0.4× 66 0.2× 166 0.6× 30 0.1× 18 592
R Pfister United Kingdom 10 655 0.7× 1.4k 1.5× 20 0.1× 486 1.8× 12 0.1× 13 1.6k
Alicja Grzanka Poland 17 144 0.1× 183 0.2× 40 0.1× 51 0.2× 14 0.1× 49 630
Francesco Tarantini Italy 11 152 0.2× 246 0.3× 30 0.1× 176 0.7× 39 0.2× 36 450

Countries citing papers authored by G. K. Scadding

Since Specialization
Citations

This map shows the geographic impact of G. K. Scadding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. K. Scadding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. K. Scadding more than expected).

Fields of papers citing papers by G. K. Scadding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. K. Scadding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. K. Scadding. The network helps show where G. K. Scadding may publish in the future.

Co-authorship network of co-authors of G. K. Scadding

This figure shows the co-authorship network connecting the top 25 collaborators of G. K. Scadding. A scholar is included among the top collaborators of G. K. Scadding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. K. Scadding. G. K. Scadding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Angela & G. K. Scadding. (2008). Is reliance on self-medication and pharmacy care adequate for rhinitis patients?. International Journal of Clinical Practice. 63(1). 98–104. 18 indexed citations
2.
Bousquet, Jean, G. K. Scadding, & A. Paul Williams. (2008). Enquête sur le poids de la rhinite allergique en France. Revue Française d Allergologie et d Immunologie Clinique. 48(5). 382–389. 7 indexed citations
3.
Canonica, Giorgio Walter, Jean Bousquet, Joaquim Mullol, G. K. Scadding, & JC Virchow. (2007). A survey of the burden of allergic rhinitis in Europe. Allergy. 62(s85). 17–25. 358 indexed citations
4.
Ogata, Noboru, Y. Darby, & G. K. Scadding. (2007). Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. The Journal of Laryngology & Otology. 121(12). 1156–1160. 32 indexed citations
5.
Ebbens, Fenna A., G. K. Scadding, Lydia Badia, et al.. (2006). Amphotericin B nasal lavages: Not a solution for patients with chronic rhinosinusitis. Journal of Allergy and Clinical Immunology. 118(5). 1149–1156. 149 indexed citations
6.
Ragab, Sameh M., G. K. Scadding, V J Lund, & Hesham Saleh. (2006). Treatment of chronic rhinosinusitis and its effects on asthma. European Respiratory Journal. 28(1). 68–74. 104 indexed citations
7.
Pereira, Susana, Tannia S. Clark, Y. Darby, et al.. (2003). Effects of anti-eotaxin monoclonal antibody CAT-213 on allergen-induced rhinitis. Journal of Allergy and Clinical Immunology. 111(2). S268–S268. 10 indexed citations
8.
Scadding, G. K.. (2001). Non-allergic rhinitis: diagnosis and management. Current Opinion in Allergy and Clinical Immunology. 1(1). 15–20. 25 indexed citations
9.
Ragab, Sameh M., Abhi Parikh, Y. Darby, & G. K. Scadding. (2001). An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clinical & Experimental Allergy. 31(9). 1385–1391. 87 indexed citations
10.
Jacobson, Mikila R., Keisuke Masuyama, Fiona O’Brien, et al.. (1999). Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy. 54(4). 338–345. 39 indexed citations
11.
Scadding, G. K., et al.. (1999). Mizolastine is Effective and Well Tolerated in Long-Term Treatment of Perennial Allergic Rhinoconjunctivitis. Journal of International Medical Research. 27(6). 273–285. 13 indexed citations
12.
Bachert, Claus, et al.. (1998). Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. Allergy. 53(10). 969–975. 29 indexed citations
13.
Darby, Y., et al.. (1997). Immediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivo. Clinical Otolaryngology. 22(4). 318–322. 34 indexed citations
14.
Dear, James W., Klaus Wirth, G. K. Scadding, & J.C. Foreman. (1996). Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]‐Hoe 140. British Journal of Pharmacology. 119(5). 1054–1062. 12 indexed citations
16.
Foreman, J.C., et al.. (1994). Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen‐induced nasal blockage. British Journal of Pharmacology. 111(4). 969–971. 48 indexed citations
17.
Goldblatt, David, et al.. (1994). Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis.. The Journal of Immunology. 153(11). 5316–5320. 25 indexed citations
18.
Scadding, G. K., et al.. (1994). Effect of short‐term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.. British Journal of Clinical Pharmacology. 38(5). 447–451. 9 indexed citations
19.
Scadding, G. K., et al.. (1991). Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis.. PubMed. 11. 37–43. 22 indexed citations
20.
Hudspith, B N, et al.. (1989). Nasal histamine release following hyperosmolar and allergen challenge. Allergy. 44(1). 25–29. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026